 | • レポートコード：QYR2104Z3509 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、リソソーム蓄積症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、基質減少療法、シスチン枯渇剤）、用途別市場規模（病院、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・リソソーム蓄積症の市場動向 ・企業の競争状況、市場シェア ・リソソーム蓄積症の種類別市場規模（酵素補充療法、基質減少療法、シスチン枯渇剤） ・リソソーム蓄積症の用途別市場規模（病院、外来手術センター） ・リソソーム蓄積症の北米市場規模2016-2027（アメリカ、カナダ） ・リソソーム蓄積症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・リソソーム蓄積症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・リソソーム蓄積症の中南米市場規模2016-2027（メキシコ、ブラジル） ・リソソーム蓄積症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Actelion Pharmaceuticals、BioMarin、Genzyme、Takeda、Alexion Pharmaceuticals、Amicus Therapeutics、Chiesi Farmaceutici、Greenovation Biotech And FGK Clinical Research、Horizon Pharma、Leadiant Biosciences、Mylan） ・結論 |
Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.
According to the report, one driver in the market is unmet medical needs.
Market Analysis and Insights: Global Lysosomal Storage Diseases Market
The global Lysosomal Storage Diseases market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lysosomal Storage Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lysosomal Storage Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lysosomal Storage Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lysosomal Storage Diseases market.
Global Lysosomal Storage Diseases Scope and Market Size
Lysosomal Storage Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lysosomal Storage Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Enzyme Replacement Therapy
Substrate Reduction Therapy
Cystine Depleting Agents
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Actelion Pharmaceuticals
BioMarin
Genzyme
Takeda
Alexion Pharmaceuticals
Amicus Therapeutics
Chiesi Farmaceutici
Greenovation Biotech And FGK Clinical Research
Horizon Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enzyme Replacement Therapy
1.2.3 Substrate Reduction Therapy
1.2.4 Cystine Depleting Agents
1.3 Market by Application
1.3.1 Global Lysosomal Storage Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lysosomal Storage Diseases Market Perspective (2016-2027)
2.2 Lysosomal Storage Diseases Growth Trends by Regions
2.2.1 Lysosomal Storage Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lysosomal Storage Diseases Historic Market Share by Regions (2016-2021)
2.2.3 Lysosomal Storage Diseases Forecasted Market Size by Regions (2022-2027)
2.3 Lysosomal Storage Diseases Industry Dynamic
2.3.1 Lysosomal Storage Diseases Market Trends
2.3.2 Lysosomal Storage Diseases Market Drivers
2.3.3 Lysosomal Storage Diseases Market Challenges
2.3.4 Lysosomal Storage Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lysosomal Storage Diseases Players by Revenue
3.1.1 Global Top Lysosomal Storage Diseases Players by Revenue (2016-2021)
3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Players (2016-2021)
3.2 Global Lysosomal Storage Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lysosomal Storage Diseases Revenue
3.4 Global Lysosomal Storage Diseases Market Concentration Ratio
3.4.1 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Diseases Revenue in 2020
3.5 Lysosomal Storage Diseases Key Players Head office and Area Served
3.6 Key Players Lysosomal Storage Diseases Product Solution and Service
3.7 Date of Enter into Lysosomal Storage Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lysosomal Storage Diseases Breakdown Data by Type
4.1 Global Lysosomal Storage Diseases Historic Market Size by Type (2016-2021)
4.2 Global Lysosomal Storage Diseases Forecasted Market Size by Type (2022-2027)
5 Lysosomal Storage Diseases Breakdown Data by Application
5.1 Global Lysosomal Storage Diseases Historic Market Size by Application (2016-2021)
5.2 Global Lysosomal Storage Diseases Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lysosomal Storage Diseases Market Size (2016-2027)
6.2 North America Lysosomal Storage Diseases Market Size by Type
6.2.1 North America Lysosomal Storage Diseases Market Size by Type (2016-2021)
6.2.2 North America Lysosomal Storage Diseases Market Size by Type (2022-2027)
6.2.3 North America Lysosomal Storage Diseases Market Size by Type (2016-2027)
6.3 North America Lysosomal Storage Diseases Market Size by Application
6.3.1 North America Lysosomal Storage Diseases Market Size by Application (2016-2021)
6.3.2 North America Lysosomal Storage Diseases Market Size by Application (2022-2027)
6.3.3 North America Lysosomal Storage Diseases Market Size by Application (2016-2027)
6.4 North America Lysosomal Storage Diseases Market Size by Country
6.4.1 North America Lysosomal Storage Diseases Market Size by Country (2016-2021)
6.4.2 North America Lysosomal Storage Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Lysosomal Storage Diseases Market Size (2016-2027)
7.2 Europe Lysosomal Storage Diseases Market Size by Type
7.2.1 Europe Lysosomal Storage Diseases Market Size by Type (2016-2021)
7.2.2 Europe Lysosomal Storage Diseases Market Size by Type (2022-2027)
7.2.3 Europe Lysosomal Storage Diseases Market Size by Type (2016-2027)
7.3 Europe Lysosomal Storage Diseases Market Size by Application
7.3.1 Europe Lysosomal Storage Diseases Market Size by Application (2016-2021)
7.3.2 Europe Lysosomal Storage Diseases Market Size by Application (2022-2027)
7.3.3 Europe Lysosomal Storage Diseases Market Size by Application (2016-2027)
7.4 Europe Lysosomal Storage Diseases Market Size by Country
7.4.1 Europe Lysosomal Storage Diseases Market Size by Country (2016-2021)
7.4.2 Europe Lysosomal Storage Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lysosomal Storage Diseases Market Size (2016-2027)
8.2 Asia-Pacific Lysosomal Storage Diseases Market Size by Type
8.2.1 Asia-Pacific Lysosomal Storage Diseases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lysosomal Storage Diseases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lysosomal Storage Diseases Market Size by Type (2016-2027)
8.3 Asia-Pacific Lysosomal Storage Diseases Market Size by Application
8.3.1 Asia-Pacific Lysosomal Storage Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lysosomal Storage Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lysosomal Storage Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific Lysosomal Storage Diseases Market Size by Region
8.4.1 Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lysosomal Storage Diseases Market Size (2016-2027)
9.2 Latin America Lysosomal Storage Diseases Market Size by Type
9.2.1 Latin America Lysosomal Storage Diseases Market Size by Type (2016-2021)
9.2.2 Latin America Lysosomal Storage Diseases Market Size by Type (2022-2027)
9.2.3 Latin America Lysosomal Storage Diseases Market Size by Type (2016-2027)
9.3 Latin America Lysosomal Storage Diseases Market Size by Application
9.3.1 Latin America Lysosomal Storage Diseases Market Size by Application (2016-2021)
9.3.2 Latin America Lysosomal Storage Diseases Market Size by Application (2022-2027)
9.3.3 Latin America Lysosomal Storage Diseases Market Size by Application (2016-2027)
9.4 Latin America Lysosomal Storage Diseases Market Size by Country
9.4.1 Latin America Lysosomal Storage Diseases Market Size by Country (2016-2021)
9.4.2 Latin America Lysosomal Storage Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lysosomal Storage Diseases Market Size (2016-2027)
10.2 Middle East & Africa Lysosomal Storage Diseases Market Size by Type
10.2.1 Middle East & Africa Lysosomal Storage Diseases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lysosomal Storage Diseases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lysosomal Storage Diseases Market Size by Type (2016-2027)
10.3 Middle East & Africa Lysosomal Storage Diseases Market Size by Application
10.3.1 Middle East & Africa Lysosomal Storage Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lysosomal Storage Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lysosomal Storage Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa Lysosomal Storage Diseases Market Size by Country
10.4.1 Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Actelion Pharmaceuticals
11.1.1 Actelion Pharmaceuticals Company Details
11.1.2 Actelion Pharmaceuticals Business Overview
11.1.3 Actelion Pharmaceuticals Lysosomal Storage Diseases Introduction
11.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.1.5 Actelion Pharmaceuticals Recent Development
11.2 BioMarin
11.2.1 BioMarin Company Details
11.2.2 BioMarin Business Overview
11.2.3 BioMarin Lysosomal Storage Diseases Introduction
11.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.2.5 BioMarin Recent Development
11.3 Genzyme
11.3.1 Genzyme Company Details
11.3.2 Genzyme Business Overview
11.3.3 Genzyme Lysosomal Storage Diseases Introduction
11.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.3.5 Genzyme Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Lysosomal Storage Diseases Introduction
11.4.4 Takeda Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Alexion Pharmaceuticals
11.5.1 Alexion Pharmaceuticals Company Details
11.5.2 Alexion Pharmaceuticals Business Overview
11.5.3 Alexion Pharmaceuticals Lysosomal Storage Diseases Introduction
11.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.5.5 Alexion Pharmaceuticals Recent Development
11.6 Amicus Therapeutics
11.6.1 Amicus Therapeutics Company Details
11.6.2 Amicus Therapeutics Business Overview
11.6.3 Amicus Therapeutics Lysosomal Storage Diseases Introduction
11.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.6.5 Amicus Therapeutics Recent Development
11.7 Chiesi Farmaceutici
11.7.1 Chiesi Farmaceutici Company Details
11.7.2 Chiesi Farmaceutici Business Overview
11.7.3 Chiesi Farmaceutici Lysosomal Storage Diseases Introduction
11.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.7.5 Chiesi Farmaceutici Recent Development
11.8 Greenovation Biotech And FGK Clinical Research
11.8.1 Greenovation Biotech And FGK Clinical Research Company Details
11.8.2 Greenovation Biotech And FGK Clinical Research Business Overview
11.8.3 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Introduction
11.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.8.5 Greenovation Biotech And FGK Clinical Research Recent Development
11.9 Horizon Pharma
11.9.1 Horizon Pharma Company Details
11.9.2 Horizon Pharma Business Overview
11.9.3 Horizon Pharma Lysosomal Storage Diseases Introduction
11.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.9.5 Horizon Pharma Recent Development
11.10 Leadiant Biosciences
11.10.1 Leadiant Biosciences Company Details
11.10.2 Leadiant Biosciences Business Overview
11.10.3 Leadiant Biosciences Lysosomal Storage Diseases Introduction
11.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.10.5 Leadiant Biosciences Recent Development
11.11 Mylan
11.11.1 Mylan Company Details
11.11.2 Mylan Business Overview
11.11.3 Mylan Lysosomal Storage Diseases Introduction
11.11.4 Mylan Revenue in Lysosomal Storage Diseases Business (2016-2021)
11.11.5 Mylan Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lysosomal Storage Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Substrate Reduction Therapy
Table 4. Key Players of Cystine Depleting Agents
Table 5. Global Lysosomal Storage Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lysosomal Storage Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lysosomal Storage Diseases Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Lysosomal Storage Diseases Market Share by Regions (2016-2021)
Table 9. Global Lysosomal Storage Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Lysosomal Storage Diseases Market Share by Regions (2022-2027)
Table 11. Lysosomal Storage Diseases Market Trends
Table 12. Lysosomal Storage Diseases Market Drivers
Table 13. Lysosomal Storage Diseases Market Challenges
Table 14. Lysosomal Storage Diseases Market Restraints
Table 15. Global Lysosomal Storage Diseases Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Lysosomal Storage Diseases Market Share by Players (2016-2021)
Table 17. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Storage Diseases as of 2020)
Table 18. Ranking of Global Top Lysosomal Storage Diseases Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Lysosomal Storage Diseases Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lysosomal Storage Diseases Product Solution and Service
Table 22. Date of Enter into Lysosomal Storage Diseases Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lysosomal Storage Diseases Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Lysosomal Storage Diseases Revenue Market Share by Type (2016-2021)
Table 26. Global Lysosomal Storage Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Lysosomal Storage Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Lysosomal Storage Diseases Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Lysosomal Storage Diseases Revenue Market Share by Application (2016-2021)
Table 30. Global Lysosomal Storage Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Lysosomal Storage Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Lysosomal Storage Diseases Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Lysosomal Storage Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Lysosomal Storage Diseases Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Lysosomal Storage Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Lysosomal Storage Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Lysosomal Storage Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Lysosomal Storage Diseases Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Lysosomal Storage Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Lysosomal Storage Diseases Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Lysosomal Storage Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Lysosomal Storage Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Lysosomal Storage Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Lysosomal Storage Diseases Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Lysosomal Storage Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Lysosomal Storage Diseases Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Lysosomal Storage Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Lysosomal Storage Diseases Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Lysosomal Storage Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Lysosomal Storage Diseases Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Lysosomal Storage Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Lysosomal Storage Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Lysosomal Storage Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Lysosomal Storage Diseases Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Lysosomal Storage Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Lysosomal Storage Diseases Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Lysosomal Storage Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 62. Actelion Pharmaceuticals Company Details
Table 63. Actelion Pharmaceuticals Business Overview
Table 64. Actelion Pharmaceuticals Lysosomal Storage Diseases Product
Table 65. Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 66. Actelion Pharmaceuticals Recent Development
Table 67. BioMarin Company Details
Table 68. BioMarin Business Overview
Table 69. BioMarin Lysosomal Storage Diseases Product
Table 70. BioMarin Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 71. BioMarin Recent Development
Table 72. Genzyme Company Details
Table 73. Genzyme Business Overview
Table 74. Genzyme Lysosomal Storage Diseases Product
Table 75. Genzyme Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 76. Genzyme Recent Development
Table 77. Takeda Company Details
Table 78. Takeda Business Overview
Table 79. Takeda Lysosomal Storage Diseases Product
Table 80. Takeda Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 81. Takeda Recent Development
Table 82. Alexion Pharmaceuticals Company Details
Table 83. Alexion Pharmaceuticals Business Overview
Table 84. Alexion Pharmaceuticals Lysosomal Storage Diseases Product
Table 85. Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 86. Alexion Pharmaceuticals Recent Development
Table 87. Amicus Therapeutics Company Details
Table 88. Amicus Therapeutics Business Overview
Table 89. Amicus Therapeutics Lysosomal Storage Diseases Product
Table 90. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 91. Amicus Therapeutics Recent Development
Table 92. Chiesi Farmaceutici Company Details
Table 93. Chiesi Farmaceutici Business Overview
Table 94. Chiesi Farmaceutici Lysosomal Storage Diseases Product
Table 95. Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 96. Chiesi Farmaceutici Recent Development
Table 97. Greenovation Biotech And FGK Clinical Research Company Details
Table 98. Greenovation Biotech And FGK Clinical Research Business Overview
Table 99. Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 100. Greenovation Biotech And FGK Clinical Research Recent Development
Table 101. Horizon Pharma Company Details
Table 102. Horizon Pharma Business Overview
Table 103. Horizon Pharma Lysosomal Storage Diseases Product
Table 104. Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 105. Horizon Pharma Recent Development
Table 106. Leadiant Biosciences Company Details
Table 107. Leadiant Biosciences Business Overview
Table 108. Leadiant Biosciences Lysosomal Storage Diseases Product
Table 109. Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 110. Leadiant Biosciences Recent Development
Table 111. Mylan Company Details
Table 112. Mylan Business Overview
Table 113. Mylan Lysosomal Storage Diseases Product
Table 114. Mylan Revenue in Lysosomal Storage Diseases Business (2016-2021) & (US$ Million)
Table 115. Mylan Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lysosomal Storage Diseases Market Share by Type: 2020 VS 2027
Figure 2. Enzyme Replacement Therapy Features
Figure 3. Substrate Reduction Therapy Features
Figure 4. Cystine Depleting Agents Features
Figure 5. Global Lysosomal Storage Diseases Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Lysosomal Storage Diseases Report Years Considered
Figure 9. Global Lysosomal Storage Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Lysosomal Storage Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Lysosomal Storage Diseases Market Share by Regions: 2020 VS 2027
Figure 12. Global Lysosomal Storage Diseases Market Share by Regions (2022-2027)
Figure 13. Global Lysosomal Storage Diseases Market Share by Players in 2020
Figure 14. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Storage Diseases as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Lysosomal Storage Diseases Revenue in 2020
Figure 16. Global Lysosomal Storage Diseases Revenue Market Share by Type (2016-2021)
Figure 17. Global Lysosomal Storage Diseases Revenue Market Share by Type (2022-2027)
Figure 18. North America Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Lysosomal Storage Diseases Market Share by Type (2016-2027)
Figure 20. North America Lysosomal Storage Diseases Market Share by Application (2016-2027)
Figure 21. North America Lysosomal Storage Diseases Market Share by Country (2016-2027)
Figure 22. United States Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Lysosomal Storage Diseases Market Share by Type (2016-2027)
Figure 26. Europe Lysosomal Storage Diseases Market Share by Application (2016-2027)
Figure 27. Europe Lysosomal Storage Diseases Market Share by Country (2016-2027)
Figure 28. Germany Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Lysosomal Storage Diseases Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Lysosomal Storage Diseases Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Lysosomal Storage Diseases Market Share by Region (2016-2027)
Figure 38. China Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Lysosomal Storage Diseases Market Share by Type (2016-2027)
Figure 46. Latin America Lysosomal Storage Diseases Market Share by Application (2016-2027)
Figure 47. Latin America Lysosomal Storage Diseases Market Share by Country (2016-2027)
Figure 48. Mexico Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Lysosomal Storage Diseases Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Lysosomal Storage Diseases Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Lysosomal Storage Diseases Market Share by Country (2016-2027)
Figure 54. Turkey Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Lysosomal Storage Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 58. BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 59. Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 60. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 61. Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 62. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 63. Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 64. Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 65. Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 66. Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 67. Mylan Revenue Growth Rate in Lysosomal Storage Diseases Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年） Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells. The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Market Analysis and Insights: Glob…- 世界のリソソーム蓄積症（LSD）市場規模・現状・予測（2021年-2027年） Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Dis…
- 世界の希少疾患市場規模・現状・予測（2021年-2027年） An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases hav…
- 世界の先天性心疾患市場規模・現状・予測（2021年-2027年） Congenital diseases are disorders in a newborn due to certain genetic factors (and sometimes in association with the environment) that often results in malformations or underdeveloped organs. Congenital Heart Diseases (CHD) results in malformed or undeveloped heart that presents in a newborn with br…
- 世界の持続的腎代替療法（CRRT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Continuous Renal Replacement Therapy Market The global Continuous Renal Replacement Therapy market size is projected to reach US$ 999.1 million by 2026, from US$ 755.5 million in 2019, at a CAGR of 4.0% during 2021-2026. With industry-standard accuracy in analysi…